课题基金 / 基金详情

Analysis of mechanism of tress-responsive and temperature-sensitive nuclear transport

Analysis of mechanism of tress-responsive and temperature-sensitive nuclear transport
应力响应和温度敏感的核运输机制分析
批准号:
13460035
负责人:
YOSHIDA Minoru
金额:
$10.75万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YOSHIDA Minoru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The target molecule of leptomycin B (LMB), a potent antitumor agent, was genetically and biochemically identified as CRM1 , a protein reported as being required for chromosome structure control. We showed that CRM1 was a receptor for the nuclear export signal (NES) and that LMB inhibited nuclear export of proteins. It therefore became able to easily determine whether a protein of interest can be exported from the nucleus by using LMB. Mouse temperature-sensitive p53^<Val135> (tsp53) accumulates in the nucleus and acts as a wild-type at 32℃, while it is sequestered in the cytoplasm at 37℃. The cytoplasmic tsp53 relocalized into the nucleus upon inhibition of the nudear export by LMB at 37℃, whereas a mutation in a major bipartite NLS caused constitutive cytoplasmic localization, indicating that it shuttled between the cytoplasm and the nucleus by its NES and NLS rather than tethered to cytoplasmic structures. We showed that the association with the Hsc70-containing complex prevents the NLS from the access of the import receptor through the C- terminal region of tsp53 at 37℃, whereas its dissociation at 32℃ allows rapid nuclear import. Using LMB, we identified a novel NES in the fission yeast transcription factor Pap1 , the function of which is abolished by oxidative stress in a manner conserved in eukaryotes. A single mutation in Crm1 (Cys-529 to Ser) caused a marked decrease in exporting Pap1 but not other typical NESs. These results suggest that the cysteine residue in Crm1 is involved in the stress-responsive nuclear export of Pap1.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
Zeng, R. et al.: "Stat5B shuttles between cytoplasm and nucleus in cytokine-dependent and independent manners"J. Immunol.. 168. 4567-4575 (2002)
Zeng, R. 等人:“Stat5B 以细胞因子依赖和独立的方式在细胞质和细胞核之间穿梭”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zeng, R., et al.: "Stat5B shuttles between cytoplasm and nucleus in cytokine-dependent and independent manners"J.Immunol.. 168. 4567-4575 (2002)
Zeng, R., et al.:“Stat5B 以细胞因子依赖和独立的方式在细胞质和细胞核之间穿梭”J.Immunol.. 168. 4567-4575 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Jang, B.-C., et al.: "Leptomycin B, an inhibitor of nuclear export receptor CRM1, inhibits COX-2 expression"J.Biol.Chem.. 278(in press). (2003)
Jang, B.-C. 等人:“Leptomycin B,核输出受体 CRM1 的抑制剂,抑制 COX-2 表达”J.Biol.Chem.. 278(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eleftheriou, et al.: "Nuclear export of human β-catenin can occur independent of CRM1 and APC"J. Biol. Chem.. 276. 25883-25888 (2001)
Eleftheriou 等人:“人 β-连环蛋白的核输出可以独立于 CRM1 和 APC”J. Biol. 276. 25883-25888 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Is transcription factor TEAD a missing protein lysine fatty acyltransferase?
    • 批准号:
      19K22271
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2019
    • 负责人:
      YOSHIDA Minoru
    • 依托单位:
    Analysis of lifestyle and health texts on the WWW consisting of text and numeric data.
    • 批准号:
      18K11549
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2018
    • 负责人:
      YOSHIDA Minoru
    • 依托单位:
    Development of fiber laser that enables high-energy-efficiency and improvement of output power that mainly used domestic technology
    • 批准号:
      26390090
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      YOSHIDA Minoru
    • 依托单位:
    Neurobehavioral effects in mice exposed to low-level mercury vapor and methylmercury during developing stage.
    • 批准号:
      24590755
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      YOSHIDA Minoru
    • 依托单位:
    国内基金
    海外基金
    抑制CRM1介导的NCOR2-HDAC3复合体核输出在阿尔茨海默病中的作用及相关机制研究
    • 批准号:
      82371194
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      杜烨鸿
    • 依托单位:
    CRM1介导ASC出核促进炎症小体活化的机制研究
    • 批准号:
      82371768
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      王夏琼
    • 依托单位:
    筛选设计非共价结合的更低毒性的CRM1抑制剂
    • 批准号:
      82273850
    • 项目类别:
      面上项目
    • 资助金额:
      76万元
    • 批准年份:
      2022
    • 负责人:
      孙庆祥
    • 依托单位:
    神经营养因子GDNF调控Survivin/CRM1在角膜缘干细胞促进组织修复再生的机理研究
    • 批准号:
      81970771
    • 项目类别:
      面上项目
    • 资助金额:
      55.0万元
    • 批准年份:
      2019
    • 负责人:
      董诺
    • 依托单位: